Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:04 PM
Ignite Modification Date:
2025-12-24 @ 5:04 PM
NCT ID:
NCT02094950
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of Lung Cancer (Non small cell and small cell both eligible)
* Completion of concurrent CRT at least 6 months prior to randomization.
* Dyspnea which worsened after Chemoradiotherapy, leading to a ATS dyspnea score greater than or equal to 2 (Walks slower than people of the same age on the level because of breathlessness or has to stop for breath when walking at own pace on level)
* Ability to understand written English -Willingness to adhere to all study-related procedures
* Age 18 years old
* ECOG Performance Status 1-3
Exclusion Criteria:
* Current receipt of therapy for treatment related pneumonitis for 3 weeks.
* Surgical resection of this LC (lobectomy or pneumonectomy)
* Another organic cause of dyspnea necessitating treatment (eg pleural effusion appropriate for thoracentesis, rapidly progressive intrathoracic recurrence, symptomatic pulmonary embolus after CRT, untreated anemia with hemoglobin8 g/dL)
* Current bleeding disorder by history
* Life expectancy of 12 weeks, as assessed by primary oncologist
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02094950
Study Brief:
Protocol Section:
NCT02094950